European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moremAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of
Read moreNew York, New York–(Newsfile Corp. – April 1, 2021) – Enerkon Solar International (OTC Pink: ENKS) names new Board and
Read moreCanada NewsWire After recently launching its Advanced Analytical Testing services, CBDV successfully receives orders through their new online payment platform
Read moreCanada NewsWire TORONTO , April 5, 2021 /CNW/ – On Tuesday, March 30, 2021 , Anthony Durkacz , a
Read moreCanada NewsWire OXFORD, Ohio and COCONUT CREEK, Fla. , March 23, 2021 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB)
Read moreDrug compound’s target therapeutic area include solid cancers and COVID-19 Canada NewsWire SINGAPORE , March 22, 2021 /CNW/ — Xylonix,
Read moreToronto, Ontario–(Newsfile Corp. – March 22, 2021) – FACT, Inc. (OTC Pink: FCTI) (the “Company” or “FACT“) a global leader
Read moreCanada NewsWire The Company expects to have ibogaine manufactured and in use for research by Q4. VANCOUVER, BC , March
Read moreBentonville, Arkansas–(Newsfile Corp. – March 1, 2021) – GLUCODOWN® (OTC Pink: GLUC) revenues at Amazon for the month of February 2021
Read moreADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific
Read more